UnitedHealth Group Incorporated $UNH Shares Purchased by Corient Private Wealth LP

Corient Private Wealth LP lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,443.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,447,224 shares of the healthcare conglomerate’s stock after purchasing an additional 7,900,011 shares during the quarter. UnitedHealth Group accounts for about 2.6% of Corient Private Wealth LP’s portfolio, making the stock its 7th largest position. Corient Private Wealth LP’s holdings in UnitedHealth Group were worth $3,510,920,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of UNH. Sarver Vrooman Wealth Advisors bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Anfield Capital Management LLC boosted its position in UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $27,000. Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $29,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. BMO Capital Markets set a $512.00 price target on UnitedHealth Group in a research report on Tuesday, July 21st. Weiss Ratings cut UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 28th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.19% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $394.57 on Friday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a market capitalization of $354.16 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The firm has a fifty day simple moving average of $413.42 and a two-hundred day simple moving average of $359.88. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period last year, the business earned $4.08 EPS. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.